Is this study's primary condition wrong?
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
- The registry's first term
- Hyperlipoproteinemia Type II
- ClinicalTrials.gg shows
- Homozygous Familial Hypercholesterolemia